VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 190 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,430,000 | -13.4% | 105,900 | -28.1% | 0.14% | -15.2% |
| Q2 2018 | $2,806,000 | -36.5% | 147,300 | -43.8% | 0.16% | -41.8% |
| Q1 2018 | $4,418,000 | -24.2% | 262,200 | -31.6% | 0.28% | -9.6% |
| Q4 2017 | $5,827,000 | -8.1% | 383,400 | +8.2% | 0.31% | -8.2% |
| Q3 2017 | $6,343,000 | +32.6% | 354,400 | +20.8% | 0.34% | +15.3% |
| Q2 2017 | $4,782,000 | +72.1% | 293,400 | +47.8% | 0.30% | +67.6% |
| Q1 2017 | $2,779,000 | +265.7% | 198,500 | +316.1% | 0.18% | +183.9% |
| Q4 2016 | $760,000 | +25.0% | 47,700 | -12.3% | 0.06% | +8.8% |
| Q2 2016 | $608,000 | -34.3% | 54,400 | -52.7% | 0.06% | -77.0% |
| Q2 2013 | $926,000 | – | 115,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |